- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04479592
Colonoscopy is an Aerosol Generating Procedure
Colonoscopy is an Aerosol-generating Procedure and Water-immersion Technique May Decrease the Amount of Aerosol Generated
With a commercially available particle counter, we can differentiate the particle counts of different sizes in different areas of the endoscopy room. An increase from baseline particles of < 5um during or after the procedure would suggest that the procedure is an AGP.
In this study, the particle counter from Met One Instruments model GT-526S will be used. A particle sizer is placed within 10cm of the anus, at the level of the endoscopists' face and at the level of the endoscopy nurse assistant's face The change in the particles of different sizes would be simultaneously recorded. The results of these three locations are compared to baseline and compared with each other
Study Overview
Status
Intervention / Treatment
Detailed Description
Currently, the term droplet is often taken to refer to droplets >5 microns (μm) in diameter that fall rapidly to the ground under gravity, and therefore are transmitted only over a limited distance (e.g. ≤1 m). In contrast, the term droplet nuclei refers to droplets ≤5 μm in diameter that can remain suspended in air for significant periods of time, allowing them to be transmitted over distances >1 metre. With a commercially available particle counter, we can differentiate the particle counts of different sizes in different areas of the endoscopy room. An increase from baseline particles of < 5um during or after the procedure would suggest that the procedure is an AGP.
In this study, the particle counter from Met One Instruments model GT-526S will be used. The study will be conducted in the Prince of Wales Hospital endoscopy centre. A particle sizer is placed within 10cm of the anus, at the level of the endoscopists' face and at the level of the endoscopy nurse assistant's face The change in the particles of different sizes would be simultaneously recorded. The results of these three locations are compared to baseline and compared with each other.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong, 00000
- Recruiting
- Prince of Wales Hospital
-
Contact:
- Shannon M Chan, FRCS
- Phone Number: 852-35052627
- Email: shannonchan@surgery.cuhk.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients who are planned for colonoscopy in the Prince of Wales Hospital, Hong kong
Exclusion Criteria:
- Patients where a flexible sigmoidoscopy was plannned Patients where the procedure was done in a negative pressure room Patients where the procedure was done in an endoscopy room other than the designated rooms Patients where the procedure was done under general anaesthesia
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of aerosol generated during the procedure
Time Frame: During the procedure
|
Concentration of aerosol generated during the procedure
|
During the procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shannon M Chan, FRCSEd, Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2020.200.2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Particle counter
-
Mersin UniversityNot yet recruiting
-
Yale UniversityCompleted
-
University of UtahCompleted
-
University of Alabama at BirminghamCompletedAlveolar Ridge Preservation | Alveolar Ridge AugmentationUnited States
-
Konstantinos SiontisCompleted
-
Hasselt UniversityZiekenhuis Oost-LimburgRecruiting
-
Nanospectra Biosciences, Inc.Active, not recruitingNeoplasms of the ProstateUnited States
-
Nanospectra Biosciences, Inc.CompletedNeoplasms of the ProstateUnited States
-
Eighth Affiliated Hospital, Sun Yat-sen UniversityXiangya Hospital of Central South University; Shanghai 10th People's Hospital; Second Affiliated Hospital of Zhengzhou University and other collaboratorsUnknownCoronary Artery Disease | Stable Chronic AnginaChina
-
Eli Lilly and CompanyCompleted